{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:26:53Z","timestamp":1766158013542},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AP-HM"},{"name":"ROCHE-CHUGAI"},{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171623","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T20:13:59Z","timestamp":1487189639000},"page":"e0171623","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study"],"prefix":"10.1371","volume":"12","author":[{"given":"Nathalie","family":"Balandraud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetan","family":"Texier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Muis-Pistor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Auger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Caroline","family":"Guzian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Guis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thao","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Roudier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.456","article-title":"Reactivation of Epstein-Barr virus from latency","volume":"15","author":"W Amon","year":"2005","journal-title":"Rev Med Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI110127","article-title":"Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis","volume":"67","author":"MA Alspaugh","year":"1981","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM198111193052102","article-title":"Defective EBV-specific suppressor T-cell function in rheumatoid arthritis","volume":"305","author":"G Tosato","year":"1981","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1172\/JCI111388","article-title":"Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis","volume":"73","author":"G Tosato","year":"1984","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/ard.59.7.533","article-title":"Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis","volume":"59","author":"E Toussirot","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/art.10933","article-title":"Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction","volume":"48","author":"N Balandraud","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref7","first-page":"1753","article-title":"Rheumatoid arthritis and cancer risk","volume":"32A","author":"L Mellemkjaer","year":"1996","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"Suppl 7","key":"ref8","first-page":"109","article-title":"Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients","volume":"20","author":"R San-Juan","year":"2014","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2010.03.016","article-title":"EBV viral load detection in clinical virology","volume":"48","author":"B G\u00e4rtner","year":"2010","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"issue":"604","key":"ref10","first-page":"e1","article-title":"Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey","volume":"21","author":"R San-Juan","year":"2015","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.22783","article-title":"Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis","volume":"57","author":"N Balandraud","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref12","first-page":"455","article-title":"CTLA4 blockade maximizes antitumor T-cell activation by dendritic cells presenting idiotype protein or opsonized anti-CD20 antibody-coated lymphoma cells","volume":"25","author":"FJ Hsu","year":"2002","journal-title":"J Immunother Hagerstown Md 1997"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/13543784.12.4.673","article-title":"The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis","volume":"12","author":"P Emery","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"JM Kremer","year":"2003","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa050524","article-title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition","volume":"353","author":"MC Genovese","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"ref16","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar1969","article-title":"Interleukin-6: a new therapeutic target","volume":"8","author":"JS Smolen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.bor.0000218949.19860.d1","article-title":"Interleukin-6 in rheumatoid arthritis","volume":"18","author":"N Nishimoto","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"RN Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref19","first-page":"559","article-title":"Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders","volume":"42","author":"K Paul-Pletzer","year":"2006","journal-title":"Drugs Today Barc Spain 1998"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"JS Smolen","year":"2008","journal-title":"Lancet Lond Engl"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties","volume":"5","author":"CP Larsen","year":"2005","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"ref22","first-page":"212","article-title":"Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant","volume":"12","author":"N Bassil","year":"2014","journal-title":"Exp Clin Transplant Off J Middle East Soc Organ Transplant"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jbspin.2015.07.009","article-title":"Monitoring of Epstein-Barr virus (EBV)\/cytomegalovirus (CMV)\/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis","volume":"83","author":"C Mourgues","year":"2016","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"ref24","first-page":"1","article-title":"Monitoring of Epstein-Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab","author":"M Fujieda","year":"2016","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.1780380106","article-title":"Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity","volume":"38","author":"JS Smolen","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal Data Analysis Using Generalized Linear Models","volume":"73","author":"K-Y Liang","year":"1986","journal-title":"Biometrika"},{"key":"ref28","unstructured":"R: The R Project for Statistical Computing [Internet]. [cited 4 Jul 2016]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.r-project.org\/\" xlink:type=\"simple\">https:\/\/www.r-project.org\/<\/ext-link>"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/sim.1650","article-title":"Estimating equations for association structures","volume":"23","author":"J Yan","year":"2004","journal-title":"Stat Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00002281-200405000-00014","article-title":"Rheumatoid arthritis and malignant lymphomas","volume":"16","author":"E Baecklund","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/art.22277","article-title":"Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis","volume":"54","author":"E Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"E Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"AL Smitten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JCM.38.2.613-619.2000","article-title":"High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders","volume":"38","author":"F Baldanti","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"ref35","doi-asserted-by":"crossref","first-page":"S399","DOI":"10.1111\/j.1432-2277.2000.tb02069.x","article-title":"Circulating Epstein-Barr virus DNA to monitor lymphoproliferative disease following pediatric liver transplantation","volume":"13","author":"B Gridelli","year":"2000","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"X Mariette","year":"2002","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jcv.2011.11.010","article-title":"Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation","volume":"53","author":"S Ruf","year":"2012","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/2012.jama.10857","article-title":"Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis","volume":"308","author":"MA Lopez-Olivo","year":"2012","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/keq368","article-title":"Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries","volume":"50","author":"X Mariette","year":"2011","journal-title":"Rheumatol Oxf Engl"},{"key":"ref40","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"JA Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/jrheum.120906","article-title":"Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program","volume":"40","author":"ME Weinblatt","year":"2013","journal-title":"J Rheumatol"},{"key":"ref42","article-title":"Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology\u2019s ORA registry","author":"C Lahaye","year":"2016","journal-title":"Rheumatol Oxf Engl"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/vim.2015.0035","article-title":"Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis","volume":"28","author":"GL Erre","year":"2015","journal-title":"Viral Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/ard.2006.054197","article-title":"Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody","volume":"65","author":"J Ogawa","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"ref45","first-page":"1","article-title":"Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan","author":"M Harigai","year":"2016","journal-title":"Mod Rheumatol Jpn Rheum Assoc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T13:11:27Z","timestamp":1601644287000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171623"}},"subtitle":[],"editor":[{"given":"Joseph S","family":"Pagano","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171623","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]}}}